Eventide Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $12.3M | Sell |
|
|||||
|
2025
Q2 | $15.7M | Sell |
|
|||||
|
2025
Q1 | $14.2M | Hold |
|
|||||
|
2024
Q4 | $15.6M | Buy |
|
|||||
|
2024
Q3 | $8.88M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $25.3M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.74M | Hold |
|
|||||
|
2018
Q1 | $2.55M | Sell |
|
|||||
|
2017
Q4 | $10.1M | Hold |
|
|||||
|
2017
Q3 | $12.6M | Hold |
|
|||||
|
2017
Q2 | $9.34M | Hold |
|
|||||
|
2017
Q1 | $11.5M | Hold |
|
|||||
|
2016
Q4 | $9.65M | Hold |
|
|||||
|
2016
Q3 | $10.6M | Hold |
|
|||||
|
2016
Q2 | $10.9M | Hold |
|
|||||
|
2016
Q1 | $9.36M | Hold |
|
|||||
|
2015
Q4 | $11.9M | Buy |
|
|||||
|
2015
Q3 | $10.8M | Buy |
|
|||||
|
2015
Q2 | $11.4M | Hold |
|
|||||
|
2015
Q1 | $8.84M | Sell |
|
|||||
|
2014
Q4 | $13.4M | Hold |
|
|||||
|
2014
Q3 | $10.5M | Hold |
|
|||||
|
2014
Q2 | $9.56M | Buy |
|
|||||
|
2014
Q1 | $4.71M | Buy |
|
|||||
|
2013
Q4 | $4.38M | Buy |
|